The June 2021 study showed that Onco's nanoparticle formulation of PNKP inhibitors effectively slowed the growth of cancer cells in colorectal cancer-bearing mice. The study reported an in vitro and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback